Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1989 1
1990 1
1991 1
1993 2
1994 1
1997 4
1998 1
1999 3
2000 1
2001 2
2002 2
2003 1
2004 1
2005 2
2006 5
2007 5
2008 4
2009 2
2010 5
2011 4
2012 3
2013 2
2014 1
2015 2
2016 4
2017 7
2018 4
2019 8
2020 3
2021 2
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %
The following terms were not found in PubMed: 22Remission, 5BMeSH
Page 1
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D UI) …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI …
Perceptual impact of astigmatism induction in presbyopes.
Benedi-Garcia C, Velasco-Ocana M, Dorronsoro C, Pascual D, Hernandez M, Marin G, Marcos S. Benedi-Garcia C, et al. Vision Res. 2019 Dec;165:143-151. doi: 10.1016/j.visres.2019.10.008. Epub 2019 Nov 18. Vision Res. 2019. PMID: 31751899 Free article.
Measurements were performed using a custom-developed Adaptive Optics system, which allowed correction of high order aberrations and induction of astigmatism (0.5, 1, 1.5 and 2.0 D; axis: 180, 45 and 22.5). Upon induction of astigmatism, best focus shifted tow …
Measurements were performed using a custom-developed Adaptive Optics system, which allowed correction of high order aberrations and induc …
Ovulatory response to GnRH agonist during early and late fall in mares.
Spencer KM, Podico G, Megahed AA, Jones KL, Bittar JHJ, Canisso IF. Spencer KM, et al. Theriogenology. 2022 Jun;185:140-148. doi: 10.1016/j.theriogenology.2022.03.003. Epub 2022 Mar 15. Theriogenology. 2022. PMID: 35405532
Ovulation was confirmed by ultrasonography performed at 24, 36 h post-induction and then repeated at 2-h intervals post-induction. Serum progesterone concentrations and luteal tissue area were determined daily to assess CL function. ...Cycles were grouped as early ( …
Ovulation was confirmed by ultrasonography performed at 24, 36 h post-induction and then repeated at 2-h intervals post-induction …
Mucosal healing progression after acute colitis in mice.
Vidal-Lletjós S, Andriamihaja M, Blais A, Grauso M, Lepage P, Davila AM, Gaudichon C, Leclerc M, Blachier F, Lan A. Vidal-Lletjós S, et al. World J Gastroenterol. 2019 Jul 21;25(27):3572-3589. doi: 10.3748/wjg.v25.i27.3572. World J Gastroenterol. 2019. PMID: 31367158 Free PMC article.
Although signs of colitis were severe (inflammatory cell infiltrate, crypt disarray, increased permeability) and associated with colonic luminal alterations (hyperosmolarity, dysbiosis, decrease in short-chain fatty acid content), epithelial healing processes were launched early …
Although signs of colitis were severe (inflammatory cell infiltrate, crypt disarray, increased permeability) and associated with colonic lum …
Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapy.
Hu Y, Chen A, Zheng X, Lu J, He H, Yang J, Zhang Y, Sui P, Yang J, He F, Wang Y, Xiao P, Liu X, Zhou Y, Pei D, Cheng C, Ribeiro RC, Hu S, Wang QF. Hu Y, et al. Natl Sci Rev. 2019 May;6(3):469-479. doi: 10.1093/nsr/nwz006. Epub 2019 Jan 22. Natl Sci Rev. 2019. PMID: 34691895 Free PMC article.
Complete response (CR) after two induction courses was attained in 87.0% (40/46) of patients receiving LDC/G-CSF. ...During the study period, an additional 94 consecutive children with AML treated with standard chemotherapy (SDC) for induction (80/94 (85.1%) of the …
Complete response (CR) after two induction courses was attained in 87.0% (40/46) of patients receiving LDC/G-CSF. ...During the study …
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor-Positive Lesions.
Boss M, Bos D, Frielink C, Sandker G, Bronkhorst P, van Lith SAM, Brom M, Buitinga M, Gotthardt M. Boss M, et al. J Nucl Med. 2020 Nov;61(11):1588-1593. doi: 10.2967/jnumed.119.238998. Epub 2020 May 8. J Nucl Med. 2020. PMID: 32385165 Free PMC article.
Tracer biodistribution was determined in BALB/c nude mice bearing subcutaneous CHL-GLP-1R xenografts. Induction of cellular damage and the effect on tumor growth were analyzed to determine treatment efficacy. ...In vivo, rtPDT induces cellular damage in tumors, shown by st …
Tracer biodistribution was determined in BALB/c nude mice bearing subcutaneous CHL-GLP-1R xenografts. Induction of cellular damage an …
Nephron, Wilms' tumor-1 (WT1), and synaptopodin expression in developing podocytes of mice.
Kato T, Mizuno S. Kato T, et al. Exp Anim. 2017 Aug 5;66(3):183-189. doi: 10.1538/expanim.16-0101. Epub 2017 Feb 7. Exp Anim. 2017. PMID: 28179596 Free PMC article.
Using an immunohistochemical technique, we examined the natural course of nephrin, Wilms' tumor-1 (WT1) and synaptopodin at 16.5 days of embryonic age (E16.5d) and E19.5d, 7 days of post-neonatal age (P7d) and P42d during renal development of mice. ...Based on the p …
Using an immunohistochemical technique, we examined the natural course of nephrin, Wilms' tumor-1 (WT1) and synaptopodin at 16.5 days of emb …
Estrus Synchronization of Replacement Gilts Using Estradiol Cipionate and PGF2α and Its Effects on Reproductive Outcomes.
Leal DF, Viana CHC, Almond GW, Monteiro MS, Garbossa CAP, Carnevale RF, Muro BBD, Poor AP, Pugliesi G, Nichi M, Watanabe TTN, Marques MG. Leal DF, et al. Animals (Basel). 2022 Dec 2;12(23):3393. doi: 10.3390/ani12233393. Animals (Basel). 2022. PMID: 36496915 Free PMC article.
On day12 of the estrus cycle (D0 = first day of standing estrus), 52 gilts were assigned at random to two experimental groups: non-treated gilts (CON, n = 22), serving as controls, and prolonged luteal function group (CYP, n = 30), receiving a single treatment with 10 mg o …
On day12 of the estrus cycle (D0 = first day of standing estrus), 52 gilts were assigned at random to two experimental groups: non-treated g …
Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial.
Roussel M, Moreau P, Hebraud B, Laribi K, Jaccard A, Dib M, Slama B, Dorvaux V, Royer B, Frenzel L, Zweegman S, Klein SK, Broijl A, Jie KS, Wang J, Vanquickelberghe V, de Boer C, Kampfenkel T, Gries KS, Fastenau J, Sonneveld P. Roussel M, et al. Lancet Haematol. 2020 Dec;7(12):e874-e883. doi: 10.1016/S2352-3026(20)30356-2. Lancet Haematol. 2020. PMID: 33242444 Clinical Trial.
In this prespecified secondary analysis, patient-reported outcomes were assessed using the European Organization for Research and Treatment of Cancer quality of life questionnaire-core 30-item (EORTC QLQ-C30) and EuroQol 5-dimensional descriptive system (EQ-5D-5L) question …
In this prespecified secondary analysis, patient-reported outcomes were assessed using the European Organization for Research and Treatment …
Effects of HMGB1 on Tricellular Tight Junctions via TGF-β Signaling in Human Nasal Epithelial Cells.
Ohwada K, Konno T, Kohno T, Nakano M, Ohkuni T, Miyata R, Kakuki T, Kondoh M, Takano K, Kojima T. Ohwada K, et al. Int J Mol Sci. 2021 Aug 4;22(16):8390. doi: 10.3390/ijms22168390. Int J Mol Sci. 2021. PMID: 34445093 Free PMC article.
High mobility group box-1 (HMGB1) increased by TGF-beta1 is involved in the induction of nasal inflammation and injury in patients with allergic rhinitis, chronic rhinosinusitis, and eosinophilic chronic rhinosinusitis. ...Treatment with HMGB1 decreased angulin-1/LSR and t …
High mobility group box-1 (HMGB1) increased by TGF-beta1 is involved in the induction of nasal inflammation and injury in patients wi …
87 results